Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Thompson

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Cancer Chemotherapy and Pharmacology|March 26, 2004
Plasma and cerebrospinal fluid pharmacokinetics of depsipeptide (FR901228) in nonhuman primatesStacey L Berg, Jeffery Stone, Jim J Xiao, et al.
Molecular Therapy. Methods & Clinical Development|March 12, 2016
Construction of a hybrid β-hexosaminidase subunit capable of forming stable homodimers that hydrolyze GM2 ganglioside in vivoMichael B Tropak, Sayuri Yonekawa, Subha Karumuthil-Melethil, et al.
Injury|February 4, 2020
The effects of military-wide introduction of advanced tourniquets in the Israel Defense ForcesAvishai M Tsur, Roy Nadler, Avi Benov, et al.
Cancer Chemotherapy and Pharmacology|December 2, 2008
Plasma and cerebrospinal fluid pharmacokinetics of tasidotin (ILX-651) and its metabolites in non-human primatesLindsay B Kilburn, Peter L Bonate, Susan M Blaney, et al.
European Journal of Haematology|July 11, 2024
Use of allopurinol to manage skewed 6-mercaptopurine metabolism in pediatric maintenance acute lymphoblastic leukemia treatmentMandee Lines, Ryan M Kemper, Jordan Wallace, et al.
Current Gene Therapy|September 17, 2021
Treatment of GM2 Gangliosidosis in Adult Sandhoff Mice Using an Intravenous Self-Complementary Hexosaminidase VectorKarlaina Jl Osmon, Patrick Thompson, Evan Woodley, et al.
Cancer Chemotherapy and Pharmacology|July 25, 2003
Pharmacokinetics of phenylacetate administered as a 30-min infusion in children with refractory cancerPatrick Thompson, Frank Balis, Baruti M Serabe, et al.
Blood|September 14, 2012
Structural basis of CBP/p300 recruitment in leukemia induction by E2A-PBX1Christopher M Denis, Seth Chitayat, Michael J Plevin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
Plasma and cerebrospinal fluid pharmacokinetics of imatinib after administration to nonhuman primatesKathleen Neville, Robert A Parise, Patrick Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2010
Phase 1 study of valproic acid in pediatric patients with refractory solid or CNS tumors: a children's oncology group reportJack M Su, Xiao-Nan Li, Patrick Thompson, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Cancer Chemotherapy and Pharmacology|March 26, 2004
Plasma and cerebrospinal fluid pharmacokinetics of depsipeptide (FR901228) in nonhuman primatesStacey L Berg, Jeffery Stone, Jim J Xiao, et al.
Molecular Therapy. Methods & Clinical Development|March 12, 2016
Construction of a hybrid β-hexosaminidase subunit capable of forming stable homodimers that hydrolyze GM2 ganglioside in vivoMichael B Tropak, Sayuri Yonekawa, Subha Karumuthil-Melethil, et al.
Injury|February 4, 2020
The effects of military-wide introduction of advanced tourniquets in the Israel Defense ForcesAvishai M Tsur, Roy Nadler, Avi Benov, et al.
Cancer Chemotherapy and Pharmacology|December 2, 2008
Plasma and cerebrospinal fluid pharmacokinetics of tasidotin (ILX-651) and its metabolites in non-human primatesLindsay B Kilburn, Peter L Bonate, Susan M Blaney, et al.
European Journal of Haematology|July 11, 2024
Use of allopurinol to manage skewed 6-mercaptopurine metabolism in pediatric maintenance acute lymphoblastic leukemia treatmentMandee Lines, Ryan M Kemper, Jordan Wallace, et al.
Current Gene Therapy|September 17, 2021
Treatment of GM2 Gangliosidosis in Adult Sandhoff Mice Using an Intravenous Self-Complementary Hexosaminidase VectorKarlaina Jl Osmon, Patrick Thompson, Evan Woodley, et al.
Cancer Chemotherapy and Pharmacology|July 25, 2003
Pharmacokinetics of phenylacetate administered as a 30-min infusion in children with refractory cancerPatrick Thompson, Frank Balis, Baruti M Serabe, et al.
Blood|September 14, 2012
Structural basis of CBP/p300 recruitment in leukemia induction by E2A-PBX1Christopher M Denis, Seth Chitayat, Michael J Plevin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
Plasma and cerebrospinal fluid pharmacokinetics of imatinib after administration to nonhuman primatesKathleen Neville, Robert A Parise, Patrick Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2010
Phase 1 study of valproic acid in pediatric patients with refractory solid or CNS tumors: a children's oncology group reportJack M Su, Xiao-Nan Li, Patrick Thompson, et al.
Pageof 8